We are live on ! Find out more
STJ

St Jude Medical
STJ

Delisted

STJ was delisted on the 4th of January, 2017.

486 hedge funds and large institutions have $13.5B invested in St Jude Medical in 2013 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 169 increasing their positions, 200 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 37

36% more call options, than puts

Call options by funds: $103M | Put options by funds: $75.7M

33% more funds holding in top 10

Funds holding in top 10: 912 (+3)

19% more capital invested

Capital invested by funds: $11.3B → $13.5B (+$2.18B)

5% more funds holding

Funds holding: 464486 (+22)

16% less repeat investments, than reductions

Existing positions increased: 169 | Existing positions reduced: 200

Holders
486
Holders Change
+22
Holders Change %
+4.74%
% of All Funds
15.75%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.39%
New
62
Increased
169
Reduced
200
Closed
37
Calls
$103M
Puts
$75.7M
Net Calls
+$27.4M
Net Calls Change
+$7.51M
Name Holding Trade Value Shares
Change
Change in
Stake
CS
76
Credit Suisse
Switzerland
$25.7M -$8.24M -159,925 -25%
RhumbLine Advisers
77
RhumbLine Advisers
Massachusetts
$25.5M -$167K -3,233 -0.7%
ARC
78
Absolute Return Capital
Massachusetts
$25.2M -$16.1M -311,719 -40%
Bank of America
79
Bank of America
North Carolina
$25M -$4.82M -93,601 -17%
T. Rowe Price Associates
80
T. Rowe Price Associates
Maryland
$23.3M +$41.2K +800 +0.2%
MTB
81
Mizuho Trust & Banking
Japan
$22.4M
DCM
82
Decade Capital Management
New York
$22.1M +$17.9M +346,780 +528%
Morgan Stanley
83
Morgan Stanley
New York
$21.5M +$4.83M +93,871 +31%
CC
84
Chubb Corp
New Jersey
$21.5M
NTCOC
85
Northern Trust Company of Connecticut
Connecticut
$21.2M +$4.58M +88,941 +29%
SIC
86
Schwartz Investment Counsel
Michigan
$21.1M +$788K +15,300 +4%
AQR Capital Management
87
AQR Capital Management
Connecticut
$20.8M -$12.7M -245,774 -39%
PPA
88
Parametric Portfolio Associates
Washington
$20.7M +$318K +6,172 +2%
NFA
89
Nationwide Fund Advisors
Ohio
$20.2M +$5.31M +103,011 +38%
BJ
90
BlackRock Japan
Japan
$20M +$127K +2,468 +0.7%
Axa
91
Axa
France
$18.9M -$7.21M -139,996 -28%
Millennium Management
92
Millennium Management
New York
$18.6M +$12.8M +249,375 +256%
GC
93
Guggenheim Capital
Illinois
$18.3M +$448K +8,696 +3%
Canada Life
94
Canada Life
Manitoba, Canada
$17.8M +$5.53M +107,279 +48%
Barclays
95
Barclays
United Kingdom
$17.7M +$648K +12,579 +4%
MVIP
96
Mar Vista Investment Partners
California
$17.6M +$624K +12,123 +4%
Royal Bank of Canada
97
Royal Bank of Canada
Ontario, Canada
$17.4M +$3.84M +74,477 +30%
Fisher Asset Management
98
Fisher Asset Management
Washington
$16.6M +$286K +5,552 +2%
State of Tennessee, Department of Treasury
99
State of Tennessee, Department of Treasury
Tennessee
$16.6M +$15.9M +309,300 New
Swiss National Bank
100
Swiss National Bank
Switzerland
$16.5M +$304K +5,900 +2%

STJ Hedge Fund Activity: Q3 2013 in Review

486 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q3 2013, worth a combined $13.5B — up 19% from $11.3B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new STJ positions and 37 closed out — a net gain of 25 holders — while 169 added to existing stakes and 200 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $158M. The largest seller was Fidelity Investments, cutting an estimated $100M.

  • 486 institutional investors held St Jude Medical (STJ) as of Q3 2013, up from 464 in Q2 2013.
  • Funds reported $13.5B of St Jude Medical stock for Q3 2013, up 19% quarter-over-quarter.
  • 62 funds opened new St Jude Medical positions in Q3 2013 and 37 closed out, a net change of +25 holders.
  • The largest St Jude Medical buyer in Q3 2013 was Eagle Asset Management, an estimated $158M added.
  • The largest St Jude Medical seller in Q3 2013 was Fidelity Investments, an estimated $100M sold.

Based on aggregated 13F filings for Q3 2013.